Case Study | EU registration of a Biosimilar

July 19, 2022

Have a look at a recent success story of how Asphalion achieved Marketing authorization for a biosimilar medicine for a company located in East Asia that wanted to access the EU market.

Thanks to our extensive track record of over 20 year at Asphalion we can assist you with your all CMC activities, non-CMC specific ones and with all other kind of projects.


For further information you can contact us at:

Search News & Events

  • Filter by category


Related news and events

HORIZON | siNPAIN meeting in Barcelona

The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for different stages of osteoarthritis. All siNPAIN partners are working hard to develop efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting